Patent · US Active

Corneal crosslinking with oxygenation

US10010449B2 · kind B2 · utility

6Cited by
6References
17Claims
0Family size

Assignee

Inventor

Key dates

Filing dateDec 21, 2015
Grant dateJul 3, 2018
Priority date
Expiry dateJan 30, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0048
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In corneal crosslinking by applying a photoactivated crosslinking facilitator such as riboflavin to the cornea and irradiating the cornea with light, the cornea is contacted with a liquid (33) containing a source of oxygen during irradiation. The liquid transfers oxygen to the cornea to facilitate crosslinking.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.